Movement Alert｜10x Genomics, Inc. Falls 5.4% in Regular Trading, Executive Share Reduction Plan and Sector-Wide Weakness Weigh on Shares

Market Focus

Aug 29

On August 29, 10x Genomics, Inc. fell 5.4% in regular trading, trading at $61.35/share, with turnover of $38.82 million.

On the news front, company co-founder Serge Saxonov recently filed Form 144 and Form 4 with the SEC, indicating a planned share reduction by the executive, raising market concerns over insider confidence. Meanwhile, the broader Life Sciences Tools & Services sector faced selling pressure, with Tempus AI down 7.48%, Agilent down 2.44%, and Thermo Fisher Scientific down 1.63%, amplifying downward pressure on individual names through sector linkage.

For context, the company reported Q2 results on August 6, posting a per-share loss of $0.14, narrower than the consensus estimate of a $0.24 loss, while revenue of $151.0 million exceeded the $146.7 million estimate. Full-year revenue guidance was raised to $610 million–$630 million. Despite the operational beat, the executive filing and broad sector headwinds appear to be driving the current session weakness.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/1178100645"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1178100645\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1178100645?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-29 00:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1178100645","market":"hk","top_or_hot":-1,"title":"Movement Alert｜10x Genomics, Inc. Falls 5.4% in Regular Trading, Executive Share Reduction Plan and Sector-Wide Weakness Weigh on Shares","media":"Market Focus","content":"<p><p>On August 29, 10x Genomics, Inc. fell 5.4% in regular trading, trading at $61.35/share, with turnover of $38.82 million.</p><p>On the news front, company co-founder Serge Saxonov recently filed Form 144 and Form 4 with the SEC, indicating a planned share reduction by the executive, raising market concerns over insider confidence. Meanwhile, the broader Life Sciences Tools & Services sector faced selling pressure, with Tempus AI down 7.48%, Agilent down 2.44%, and Thermo Fisher Scientific down 1.63%, amplifying downward pressure on individual names through sector linkage.</p><p>For context, the company reported Q2 results on August 6, posting a per-share loss of $0.14, narrower than the consensus estimate of a $0.24 loss, while revenue of $151.0 million exceeded the $146.7 million estimate. Full-year revenue guidance was raised to $610 million–$630 million. Despite the operational beat, the executive filing and broad sector headwinds appear to be driving the current session weakness.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜10x Genomics, Inc. Falls 5.4% in Regular Trading, Executive Share Reduction Plan and Sector-Wide Weakness Weigh on Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜10x Genomics, Inc. Falls 5.4% in Regular Trading, Executive Share Reduction Plan and Sector-Wide Weakness Weigh on Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-29 00:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 29, 10x Genomics, Inc. fell 5.4% in regular trading, trading at $61.35/share, with turnover of $38.82 million.</p><p>On the news front, company co-founder Serge Saxonov recently filed Form 144 and Form 4 with the SEC, indicating a planned share reduction by the executive, raising market concerns over insider confidence. Meanwhile, the broader Life Sciences Tools & Services sector faced selling pressure, with Tempus AI down 7.48%, Agilent down 2.44%, and Thermo Fisher Scientific down 1.63%, amplifying downward pressure on individual names through sector linkage.</p><p>For context, the company reported Q2 results on August 6, posting a per-share loss of $0.14, narrower than the consensus estimate of a $0.24 loss, while revenue of $151.0 million exceeded the $146.7 million estimate. Full-year revenue guidance was raised to $610 million–$630 million. Despite the operational beat, the executive filing and broad sector headwinds appear to be driving the current session weakness.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TXG","symbol_name":"10x Genomics, Inc.","start_time":0,"source_url":"","article_id":"1178100645","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1178100645","pubTimestamp":1787932933,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 29, 10x Genomics, Inc. fell 5.4% in regular trading, trading at $61.35/share, with turnover of $38.82 million.On the news front, company co-founder Serge Saxonov recently filed Form 144 and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TXG":"10x Genomics, Inc."},"translate_title":"走势警报|10x Genomics, Inc. 常规交易下跌 5.4%，高管减持计划和全行业疲软令股价承压","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TXG":1},"content_text":"On August 29, 10x Genomics, Inc. fell 5.4% in regular trading, trading at $61.35/share, with turnover of $38.82 million.On the news front, company co-founder Serge Saxonov recently filed Form 144 and Form 4 with the SEC, indicating a planned share reduction by the executive, raising market concerns over insider confidence. Meanwhile, the broader Life Sciences Tools & Services sector faced selling pressure, with Tempus AI down 7.48%, Agilent down 2.44%, and Thermo Fisher Scientific down 1.63%, amplifying downward pressure on individual names through sector linkage.For context, the company reported Q2 results on August 6, posting a per-share loss of $0.14, narrower than the consensus estimate of a $0.24 loss, while revenue of $151.0 million exceeded the $146.7 million estimate. Full-year revenue guidance was raised to $610 million–$630 million. Despite the operational beat, the executive filing and broad sector headwinds appear to be driving the current session weakness.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}